Skip to main content
12/12/2022

Fundación Neuroblastoma donates to VHIR more than €20,000 for research

Donacio-neuroblastoma-Tamara-Garro

12/12/2022

The funds come from the campaign "Una pizca de Magia" (A pinch of Magic) promoted by Tamara Gorro.

Tamara Gorro has donated more than 20,000 euros through the Fundación Neuroblastoma to the research group Childhood Cancer and Blood Disorders at the Vall d'Hebron Research Institute (VHIR) to boost its research lines in high-risk neuroblastoma, a very aggressive type of pediatric tumor with very few therapeutic options. The amount came from the Solidarity Market held in Madrid on November 19 by the initiative "Una Pizca de Magia" promoted by the influencer Tamara Gorro.

Tamara Gorro co-created this project with Valeria and her family. Valeria was a nine-year-old neuroblastoma patient who actively participated in this initiative. Valeria was very aware of the pollution of the planet and therefore, it was decided that the project would offer tote bags to reduce the use of plastics. She herself designed the bags that are being sold. "Una Pizca de Magia" follows the same line of sustainable initiatives that Valeria loved so much, uniting research against cancer and the reduction of plastic consumption, promoting recycling, and giving a second life to clothing and accessories donated by various celebrities. Valeria passed away in July 2022 due to her illness and this donation has been made in her honor.  

The funds will be destined for the different research lines of the Neural Tumors Laboratory directed by Dr. Miguel Segura, principal investigator of the Childhood Cancer and Blood Disorders research group at VHIR, directed by Dr. Lucas Moreno. 

The Fundación Neuroblastoma was born in 2016 with the vocation to be useful to all parents of children suffering from the disease and at the same time to bring together the efforts of all families so that the pathology is 100% curable in the future.

The funds will be destined for the different research in high-risk neuroblastoma lines of the Neural Tumors Laboratory

Related news

A study, co-led by Vall d’Hebron, has analysed the evolution of clinical trials with children and adolescents with cancer over the last 15 years, with the aim of optimising efficacy and defining lines for further progress.

The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models.

Vall d'Hebron presents positive results from two studies in transfusion-dependent thalassaemia and severe bone marrow aplasia at the EBMT Annual Meeting on haematopoietic stem cell transplantation.

Related professionals

Lucas Moreno Martín-Retortillo

Lucas Moreno Martín-Retortillo

Head of group
Childhood Cancer and Blood Disorders
Read more
Miguel Segura Ginard

Miguel Segura Ginard

Main researcher
Childhood Cancer and Blood Disorders
Read more
Maria Isabel  Benitez  Carabante

Maria Isabel Benitez Carabante

Childhood Cancer and Blood Disorders
Read more
Raquel Hladun Alvaro

Raquel Hladun Alvaro

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.